ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

FXI Fusionex

63.50
0.00 (0.00%)
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Fusionex LSE:FXI London Ordinary Share JE00B8BL8C53 ORD NPV
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 63.50 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Fusionex International PLC Trading Update (2338N)

24/10/2016 7:00am

UK Regulatory


TIDMFXI

RNS Number : 2338N

Fusionex International PLC

24 October 2016

 
 For Immediate Release   24 October 2016 
 

Fusionex International PLC

("Fusionex" or "the Group")

Trading Update

Fusionex, a multi-award winning international software solutions provider specialising in Big Data Analytics, Artificial Intelligence and the Internet of Things ("IoT"), is pleased to provide the following trading update for the year ended 30 September 2016 ("FY2016").

Building on momentum achieved in the first half of the 2016 financial year, Fusionex has continued to deliver on its strategy and make progress throughout the rest of the year. In particular, the Group successfully launched the next generation of its proprietary Big Data Analytics ("BDA") platform, 'GIANT 2016', in June 2016. In addition to providing blue-chip enterprise organisations with the most complete BDA software in its space, GIANT 2016 has opened up a new addressable market across small and medium sized businesses ("SMEs"). The pipeline for GIANT 2016 is substantial.

The Group's steady progress has underpinned a strong FY2016 financial performance. The Board anticipates that revenue will be in line with market expectations and, despite the significant planned investment in the marketing and promotion of Fusionex's products, EBITDA is expected to be significantly ahead of market expectations.

The Board expects the positive momentum experienced in FY2016 to continue in the current year.

For further information please contact:

 
 Fusionex                                     Through Buchanan 
  Ivan Teh, Chief Executive Officer 
  Yuen Choong Lai, Chief Financial 
  Officer 
  Darren Hopkins, Director of Investor 
  Relations & Corporate Development 
 Panmure Gordon (Nominated Adviser 
  and Joint Broker) 
  Andrew Godber, Alina Vaskina (Investment 
  Banking) 
  Charles Leigh-Pemberton (Corporate 
  Broking)                                       0207 886 2500 
 
   Peel Hunt LLP (Joint Broker) 
   Richard Kauffer, Euan Brown                   0207 418 8900 
 
   Buchanan 
   Sophie McNulty, Stephanie Watson, 
   Patrick Hanrahan                              0207 466 5000 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

TSTUOVWRNUARUAA

(END) Dow Jones Newswires

October 24, 2016 02:00 ET (06:00 GMT)

1 Year Fusionex Chart

1 Year Fusionex Chart

1 Month Fusionex Chart

1 Month Fusionex Chart

Your Recent History

Delayed Upgrade Clock